ID

34581

Descrizione

Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Children With Type 1 Diabetes in a Diabetes Camp; ODM derived from: https://clinicaltrials.gov/show/NCT02189694

collegamento

https://clinicaltrials.gov/show/NCT02189694

Keywords

  1. 19/01/19 19/01/19 -
Titolare del copyright

see on clinicaltrials.gov

Caricato su

19 gennaio 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Type 1 Diabetes NCT02189694

Eligibility Type 1 Diabetes NCT02189694

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
males or females between the 8 and 17 years of old.
Descrizione

ID.1

Tipo di dati

boolean

clinical diagnosis of type 1 diabetes for at least one year. the subject will have been on insulin pump therapy for at least 3 months.
Descrizione

ID.2

Tipo di dati

boolean

hba1c ≤ 11.0%.
Descrizione

ID.3

Tipo di dati

boolean

Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
clinically significant nephropathy, neuropathy or retinopathy as judged by the investigator.
Descrizione

ID.4

Tipo di dati

boolean

severe hypoglycemic episode within two weeks of inclusion in the study. a severe hypoglycemic episode is defined as loss of conscience, seizure or a hospital emergency visit.
Descrizione

ID.5

Tipo di dati

boolean

current use of oral glucocorticoid medication (except low stable dose according to investigator judgement). stable doses of inhaled steroids are acceptable.
Descrizione

ID.6

Tipo di dati

boolean

known or suspected allergy to the trial products.
Descrizione

ID.7

Tipo di dati

boolean

other serious medical illness likely to interfere with study participation or with the ability to complete the trial by the judgment of the investigator.
Descrizione

ID.8

Tipo di dati

boolean

failure to comply with team's recommendations (e.g. not willing to use trial pump, etc).
Descrizione

ID.9

Tipo di dati

boolean

Similar models

Eligibility Type 1 Diabetes NCT02189694

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
males or females between the 8 and 17 years of old.
boolean
ID.2
Item
clinical diagnosis of type 1 diabetes for at least one year. the subject will have been on insulin pump therapy for at least 3 months.
boolean
ID.3
Item
hba1c ≤ 11.0%.
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
clinically significant nephropathy, neuropathy or retinopathy as judged by the investigator.
boolean
ID.5
Item
severe hypoglycemic episode within two weeks of inclusion in the study. a severe hypoglycemic episode is defined as loss of conscience, seizure or a hospital emergency visit.
boolean
ID.6
Item
current use of oral glucocorticoid medication (except low stable dose according to investigator judgement). stable doses of inhaled steroids are acceptable.
boolean
ID.7
Item
known or suspected allergy to the trial products.
boolean
ID.8
Item
other serious medical illness likely to interfere with study participation or with the ability to complete the trial by the judgment of the investigator.
boolean
ID.9
Item
failure to comply with team's recommendations (e.g. not willing to use trial pump, etc).
boolean

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial